247 related articles for article (PubMed ID: 11318363)
1. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ
J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
4. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
[TBL] [Abstract][Full Text] [Related]
6. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
[TBL] [Abstract][Full Text] [Related]
7. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs.
Simpson AM; Ludwig LL; Newman SJ; Bergman PJ; Hottinger HA; Patnaik AK
J Am Vet Med Assoc; 2004 Jan; 224(2):236-40. PubMed ID: 14736068
[TBL] [Abstract][Full Text] [Related]
9. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
Weisse C; Shofer FS; Sorenmo K
J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
[TBL] [Abstract][Full Text] [Related]
10. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE
J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
Hahn KA; King GK; Carreras JK
J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for incompletely resected canine mast cell tumors.
LaDue T; Price GS; Dodge R; Page RL; Thrall DE
Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
14. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.
Michels GM; Knapp DW; DeNicola DB; Glickman N; Bonney P
J Am Anim Hosp Assoc; 2002; 38(5):458-66. PubMed ID: 12220031
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002).
Cahalane AK; Payne S; Barber LG; Duda LE; Henry CJ; Mauldin GE; Frimberger AE; Cotter SM; Moore AS
J Am Vet Med Assoc; 2004 Aug; 225(3):401-8. PubMed ID: 15328716
[TBL] [Abstract][Full Text] [Related]
16. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.
Murphy S; Sparkes AH; Smith KC; Blunden AS; Brearley MJ
Vet Rec; 2004 Jun; 154(24):743-6. PubMed ID: 15224593
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of scar revision after inadequate primary excision of cutaneous mast cell tumors in 85 dogs (2000-2013).
Karbe GT; Davis E; Runge JJ; Brown DC; Holt DE
Vet Surg; 2021 May; 50(4):807-815. PubMed ID: 33666268
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs.
Selmic LE; Ruple A
BMC Vet Res; 2020 Jan; 16(1):5. PubMed ID: 31906934
[TBL] [Abstract][Full Text] [Related]
20. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
Chaffin K; Thrall DE
Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
